Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapyChristophe Adrie, Hakim Haouache, Stéphane Ruckly et al.|Journal of Infection|2016Cited by 167
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA studyLiesbet De Bus, Mónica Crespo, Pieter Depuydt et al.|Intensive Care Medicine|2020Cited by 117
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean‐François Timsit, Jean‐Ralph Zahar et al.|Clinical Infectious Diseases|2019Cited by 49